HAKLIYIM
/
Trending
New
Krypto
Videnskab og teknologi
Sport
Finans
E-sport
Iran
Økonomi
Geopolitik
Politik
Kultur
Omtaler
Valg
More
All
360
AI
96
Elon Musk
36
Apple
17
SpaceX
33
OpenAI
34
Research
1
FDA
21
Big Tech
156
TikTok
0
Videnskab og teknologi
Videnskab og teknologi
All
AI
Elon Musk
Apple
SpaceX
OpenAI
Research
FDA
Big Tech
TikTok
FDA approves Retatrutide this year?
3%
chance
Yes
No
$579k Vol.
FDA approves skin cancer vaccine by...?
December 31, 2027
69%
Yes
69%
No
31%
June 30, 2027
12%
Yes
12%
No
88%
$48k Vol.
Skin cancer vaccine BLA submitted by June 30, 2027?
88%
chance
Yes
No
$39k Vol.
Who will Trump announce as next FDA commissioner?
Sara Brenner
1%
Yes
1%
No
99%
Stephen Hahn
1%
Yes
1%
No
99%
Kyle Diamantas
0%
Yes
0%
No
100%
No announcement by December 31
0%
Yes
0%
No
100%
Grace Graham
0%
Yes
0%
No
100%
Brett Giroir
0%
Yes
0%
No
100%
$35k Vol.
FDA approves Sanofi’s Subcutaneous Sarclisa?
0%
chance
Yes
No
$8k Vol.
FDA approves Outlook Therapeutics' ONS-5010?
99%
chance
Yes
No
$6k Vol.
FDA approves Arcalyst technology transfer?
9%
chance
Yes
No
$6k Vol.
FDA approves Arcutis' Zoryve cream?
89%
chance
Yes
No
$4k Vol.
FDA approves Corcept Therapeutics' Relacorilant?
100%
chance
Yes
No
$4k Vol.
FDA approves Sanofi's Subcutaneous Sarclisa?
66%
chance
Yes
No
$4k Vol.
FDA approves Unicycive's Oxylanthanum carbonate?
82%
chance
Yes
No
$4k Vol.
FDA moves BPC-157 to Category 1 by…?
December 31, 2026
55%
Yes
55%
No
45%
August 31, 2026
8%
Yes
8%
No
92%
$3k Vol.
FDA approves Ionis' Olezarsen?
88%
chance
Yes
No
$2k Vol.
FDA approves Camurus' Oclaiz?
92%
chance
Yes
No
$2k Vol.
FDA approves AstraZeneca's Camizestrant?
4%
chance
Yes
No
$2k Vol.
FDA approves MannKind's FUROSCIX ReadyFlow Autoinjector?
100%
chance
Yes
No
$778 Vol.
FDA approves Daiichi Sankyo & AstraZeneca's Enhertu?
79%
chance
Yes
No
$687 Vol.
FDA approves Celcuity's Gedatolisib?
100%
chance
Yes
No
$320 Vol.
FDA approves Merck's Welireg + Keytruda or Keytruda Qlex?
81%
chance
Yes
No
$274 Vol.
FDA approves Otsuka's Centanafadine?
39%
chance
Yes
No
$199 Vol.
FDA approves Elevar Therapeutics' Rivoceranib + camrelizumab?
50%
chance
Yes
No
$20 Vol.
Home
Search
New
More